Dopaminergic modulation of early signs of excitotoxicity in visualized rat neostriatal neurons - PubMed (original) (raw)
Dopaminergic modulation of early signs of excitotoxicity in visualized rat neostriatal neurons
C Cepeda et al. Eur J Neurosci. 1998 Nov.
Abstract
Cell swelling induced by activation of excitatory amino acid receptors is presumably the first step in a toxic cascade that may ultimately lead to cell death. Previously we showed that bath application of N-methyl-D-aspartate (NMDA) or kainate (KA) produces swelling of neostriatal cells. The present experiments examined modulation of NMDA and KA-induced cell swelling by dopamine (DA) and its receptor agonists. Nomarski optics and infra-red videomicroscopy were utilized to visualize neostriatal medium-sized neurons in thick slices from rat pups (12-18 postnatal days). Increase in somatic cross-sectional area served as the indicator of swelling induced by bath application of glutamate receptor agonists. NMDA induced cell swelling in a dose-dependent manner. Activation of DA receptors in the absence of NMDA did not produce swelling. DA and the D1 receptor agonist SKF 38393, increased the magnitude of swelling produced by NMDA. This effect was reduced in the presence of the D1 receptor antagonist, SCH 23390. In contrast, activation of D2 receptors by quinpirole decreased the magnitude of NMDA-induced cell swelling. DA slightly attenuated cell swelling induced by activation of KA receptors. Quinpirole produced a significant concentration-dependent reduction in KA-induced swelling while SKF38393 increased KA-induced swelling, but only at a low concentration of KA. Together, these results provide additional support for the hypothesis that the direction of DA modulation depends on the glutamate receptor subtype, as well as the DA receptor subtype activated. One possible consequence of these observations is that endogenous DA may be an important contributing factor in the mechanisms of cell death in Huntington's disease.
Similar articles
- Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices: contribution of calcium conductances.
Cepeda C, Colwell CS, Itri JN, Chandler SH, Levine MS. Cepeda C, et al. J Neurophysiol. 1998 Jan;79(1):82-94. doi: 10.1152/jn.1998.79.1.82. J Neurophysiol. 1998. PMID: 9425179 - Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated.
Cepeda C, Buchwald NA, Levine MS. Cepeda C, et al. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9576-80. doi: 10.1073/pnas.90.20.9576. Proc Natl Acad Sci U S A. 1993. PMID: 7692449 Free PMC article. - Effects of selective dopamine receptor compounds on single, spontaneously-active neostriatal neurons.
Nantwi KD, Schoener EP. Nantwi KD, et al. Gen Pharmacol. 1994 Nov;25(7):1439-43. doi: 10.1016/0306-3623(94)90171-6. Gen Pharmacol. 1994. PMID: 7896058 - D1 and D2 dopamine receptor modulation of sodium and potassium currents in rat neostriatal neurons.
Surmeier DJ, Kitai ST. Surmeier DJ, et al. Prog Brain Res. 1993;99:309-24. doi: 10.1016/s0079-6123(08)61354-0. Prog Brain Res. 1993. PMID: 7906427 Review. - Dopamine/glutamate interaction as studied by combining turning behaviour and c-Fos expression.
Morelli M. Morelli M. Neurosci Biobehav Rev. 1997 Jul;21(4):505-9. doi: 10.1016/s0149-7634(96)00031-0. Neurosci Biobehav Rev. 1997. PMID: 9195609 Review.
Cited by
- Proteostasis in striatal cells and selective neurodegeneration in Huntington's disease.
Margulis J, Finkbeiner S. Margulis J, et al. Front Cell Neurosci. 2014 Aug 7;8:218. doi: 10.3389/fncel.2014.00218. eCollection 2014. Front Cell Neurosci. 2014. PMID: 25147502 Free PMC article. Review. - Common key-signals in learning and neurodegeneration: focus on excito-amino acids, beta-amyloid peptides and alpha-synuclein.
Agnati LF, Leo G, Genedani S, Piron L, Rivera A, Guidolin D, Fuxe K. Agnati LF, et al. J Neural Transm (Vienna). 2009 Aug;116(8):953-74. doi: 10.1007/s00702-008-0150-4. Epub 2008 Nov 19. J Neural Transm (Vienna). 2009. PMID: 19018448 - SCH 23390: the first selective dopamine D1-like receptor antagonist.
Bourne JA. Bourne JA. CNS Drug Rev. 2001 Winter;7(4):399-414. doi: 10.1111/j.1527-3458.2001.tb00207.x. CNS Drug Rev. 2001. PMID: 11830757 Free PMC article. Review. - Dopamine D1 vs D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1/2 and GluR1-AMPA signalling.
O'Sullivan GJ, Dunleavy M, Hakansson K, Clementi M, Kinsella A, Croke DT, Drago J, Fienberg AA, Greengard P, Sibley DR, Fisone G, Henshall DC, Waddington JL. O'Sullivan GJ, et al. Neuropharmacology. 2008 Jun;54(7):1051-61. doi: 10.1016/j.neuropharm.2008.02.011. Epub 2008 Feb 21. Neuropharmacology. 2008. PMID: 18367215 Free PMC article. - Reduced threshold for induction of LTP by activation of dopamine D1/D5 receptors at hippocampal CA1-subiculum synapses.
Roggenhofer E, Fidzinski P, Shor O, Behr J. Roggenhofer E, et al. PLoS One. 2013 Apr 23;8(4):e62520. doi: 10.1371/journal.pone.0062520. Print 2013. PLoS One. 2013. PMID: 23626827 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous